The latest research by Colliers International has revealed the current global In Vitro Fertilization (IVF) market is estimated to be between US$10 billion to US$12 billion, while the current IVF market size for Middle East & North Africa (MENA) is approximately US$1 billion, indicating a high demand for IVF and related treatments in the region.
The figures, published in a new report titled “In Vitro Fertilization (IVF) & Fertility in the MENA region”, revealed that compared to 10 per cent worldwide, infertility in the MENA region is 15 per cent or higher, with male infertility a growing problem occurring in approximately 50 per cent of the cases in the GCC and Middle East due to lifestyle, diabetes, obesity and genetics related factors, as GCC countries have one of the highest diabetic and obesity rates in the world.
The report highlighted that although the population in the MENA region has increased from over 100 million in 1950 to 380 million in 2017 and is expected to increase to 700 million by 2050, overall fertility rates have decreased from seven children per women in 1960 to just three in 2017. The research provides an in-depth analysis of the fertility rates in MENA region and, despite overall high population growth rates, why IVF remains in demand in the region, especially in the GCC countries.
Mansoor Ahmed , Director Healthcare, Education & PPP for MENA Region at Colliers International, said: “IVF
is not only sought after locally but is one of the leading treatments undertaken by medical tourists in the UAE, especially in Dubai.
Based on Colliers ‘ discussions with leading operators , medical tourism accounts for 10 per cent to 15 per cent of the IVF patient volumes.”
According to the report, new innovations and improved testing techniques are gradually creating paradigm shifts in the field of assisted reproductive technology. Particularly the increased focus on pre-marital screening for consanguineous (relatives) couples and the development of new genetic tests for screening of the embryos greatly improves the chance of minimising certain genetic diseases common in this region.
